Dtsch Med Wochenschr 2009; 134(25/26): 1329-1332
DOI: 10.1055/s-0029-1225285
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Gastroenterologie 2009

Gastroenterology 2009F. Schorr1 , M. Bechtler1 , J. F. Riemann1
  • 1Medizinische Klinik C, Klinikum Ludwigshafen
Further Information

Publication History

Publication Date:
10 June 2009 (online)

Was ist neu?

  • Endoskopie: Neue Verfahren zur Dünndarmenteroskopie und Radiofrequenzablation bei Barrett-Ösophagus.

  • Ösophaguserkrankungen: Prävalenz der eosinophile Ösophagitis steigt.

  • Reizdarmsyndrom: Neue Therapieansätze

  • Chronisch entzündliche Darmerkrankungen: Langzeittherapie und postoperative Rezidivprophylaxe mit Azathioprin, Karzinomrisiko bei Morbus Crohn.

  • Gastrointestinale Onkologie: Therapie des Pankreaskarzinoms bleibt Herausforderung; Rauchen als Risikofaktor für viele gastrointestinale Karzinome, Kolonandemone und Pankreatitis.

Literatur

  • 1 Akerman P A, Cantero D, Avila J. et al . The spiral enteroscopy experience in 101 consecutive patients: safty and efficacy using the Discovery SB.  Gastrointest Endosc. 2008;  67 AB92-93
  • 2 Bechtler M, Eickhoff A, Riemann J F. Intervallkarzinom und mögliche Ursachen.  Dtsch Med Wochenschr. 2008;  133 2458-2462
  • 3 Baxter N N, Goldwasser M A, Paszat L F. et al . Association of Colonoscopy and Death From Colorectal Cancer: A Population-Based, Case–Control Study.  Ann Intern Med. 2009;  150 1-8
  • 4 Bokemeyer C, Bondarenko I, Makhson A. et al . Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer.  J Clin Oncol. 2009;  10,27 663-671
  • 5 Botteri E, Iodice S, Bagnardi V. et al . Smoking and colorectal cancer: a meta-analysis.  JAMA. 2008;  300 2765-2778
  • 6 Botteri E, Iodice S, Raimondi S. et al . Cigarette smoking and adenomatous polyps: a meta-analysis.  Gastroenterology. 2008;  134 388-395
  • 7 Buscaglia J M, Dunbar K B, Okolo P I. et al . The spiral enteroscopy training initiative: results of a prospective study evaluating the Discovery SB overtube device during small bowel enteroscopy.  Endoscopy. 2009;  41 194-199
  • 8 D’Haens G R, Vermeire S, van Assche G. et al . Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn’s disease: a controlled randomized trial.  Gastroenterology. 2008;  135 1123-1129
  • 9 Di Nicolantonio F, Martini M, Molinari F. et al . Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.  J Clin Oncol. 2008;  26 5705-5012
  • 10 Domenech E, Manosa M, Bernal I. et al . Impact of azathioprine on the prevention of postoperative Crohn’s disease recurrence: Results of a prospective, observational, long-term follow-up study.  Inflamm Bowel Dis. 2008;  14 508-513
  • 11 Fleischer D E, Overholt B F, Sharma V K. et al . Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2,5-year follow-up.  Gastrointest Endosc. 2008;  68 867-876
  • 12 Friedman S, Rubin P H, Bodian C. et al . Screening and surveillance colonoscopy in chronic Crohn’s colitis: Results of a surveillance program spanning 25 years.  Clin Gastroenterol Hepatol. 2008;  6 993-998
  • 13 Gupte A R, Draganov P V. Eosinophilic esophagitis.  World J Gastroenterol. 2009;  15 17-24
  • 14 Hartmann D, Eickhoff A, Tamm B. et al . Balloon-assisted enteroscopy using a single-balloon technique.  Endoscopy. 2007;  39 E276
  • 15 Heresbach D, Barrioz T, Lapalus M G. et al . Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies.  Endoscopy. 2008;  40 284-290
  • 16 Imperiale T F, Glowinski E A, Lin-Cooper C. et al . Five-year risk of colorectal neoplasia after negative screening colonoscopy.  N Engl J Med. 2008;  359 1218-1224
  • 17 Iodice S, Gandini S, Maisonneuve P. et al . Tobacco and the risk of pancreatic cancer: A review and metaanalysis.  Langenbecks Arch Surg. 2008;  393 535-545
  • 18 Johanson J F, Drossman D A, Panas R. et al . Phase II study of lubiprostone for irritable bowel syndrome with constipation.  Aliement Pharmacol Ther. 2008;  27 685-696
  • 19 Kapel R C, Miller J K, Torres C. et al . Eosinophilic esophagitis: Aprevalent disease in the United States that affects all age groups.  Gastroenterology. 2008;  134 1316-1321
  • 20 Kindler H L, Gangadhar T, Karrison T. et al . Final analysis of a randomized phase II study of bevacizumab (b) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients with advanced pancreatic cancer.  J Clin Oncol. 2008;  26 4502
  • 21 Kullmann F, Hollerbach S, Dollinger M M. et al . Cetuximab plus gemcitabin/oxaliplatin (GEMOXCET) in first line metastatic pancreatic cancer: a multicenter phase II study.  Br J Cancer. 2009;  100 1032-1036
  • 22 Liang P S, Chen T Y, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis.  Int J Cancer. 2009;  124 2406-2415
  • 23 Lindkvist B, Appelros S, Manjer J. et al . A prospective cohort study of smoking in acute pancreatitis.  Pancreatology. 2008;  8 63-70
  • 24 Martínez M E, Baron J A, Lieberman D A. et al . A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy.  Gastroenterology. 2009;  136 832-841
  • 25 Neuhaus P, Riess H, Post S. et al . CONKO-001: Final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer (PC).  J Clin Oncol. 2008;  26 214s; abstr LBA4504
  • 26 Picozzi V J, Abrams R A, Traverso L W. et al . ACOSOG Z05031: Report on a multicenter, phase II trial for adjuvant therapy of resected pancreatic cancer using cisplatin, 5-FU, and alpha-interferon.  J Clin Oncol. 2008;  26 4505
  • 27 Pouw R E, Sharma V K, Bergman J J. et al . Radiofrequency ablation for total Barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects.  Endoscopy. 2008;  40 1033-1040
  • 28 Sargent D J, Marsoni S, Thibodeau S N. et al . Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials.  J Clin Oncol. 2008;  26 180s; abstr 4008
  • 29 Schorr F, Riemann J F. Gastroenterologie 2008.  Dtsch Med Wochenschr. 2008;  133 1362-1365
  • 30 Tol J, Koopman M, Cats A. et al . Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.  N Engl J Med. 2009;  360 563-572
  • 31 Treton X, Bouhnik Y, Mary J Y. et al . Azathioprine withdrawal in patients with Crohn’s disease maintained on prolonged remission: a high risk of relapse.  Clin Gastroenterol Hepatol. 2009;  7 80-85
  • 32 Tsujikawa T, Saiton Y, Andoh A. et al . Novel single-ballon enteroscopy for diagnosis and treatment of the small intestine: preliminary experiences.  Endoscopy. 2008;  40 11-15
  • 33 Van Cutsem E, Lang I, D’Haens G. et al . KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience.  J Clin Oncol. 2008;  26 5s; abstr.
  • 34 Wilhelm S M, Brubaker C M, Varcak E A. et al . Effectiveness of probiotics in the treatment of irritable bowel syndrome.  Pharmacotherapy. 2008;  28 496-505
  • 35 Zijdenbos I L, de Wit N J, van der Heijden G J. et al .Cochrane Database Syst Rev 2009 CD006442

Dr. med. Friedrich Schorr

Medizinische Klinik C, Klinikum Ludwigshafen

Bremserstrasse 79

67063 Ludwigshafen am Rhein

Phone: 0621/5034104

Fax: 0621/5034114

Email: schorrf@klilu.de

    >